Simplify Logo

Full-Time

Mgr – Quality Assurance

Posted on 6/25/2024

Natera

Natera

1,001-5,000 employees

Biotechnology firm specializing in genetic testing

Biotechnology
Healthcare

Compensation Overview

$119k - $148.8kAnnually

Senior

Austin, TX, USA

Approximately 15% of work time will be spent travelling.

Category
QA & Testing
Quality Assurance
Requirements
  • Bachelor's degree in science, engineering, or relevant discipline
  • Minimum of 3 years supervisory experience
  • Minimum of 5 years experience in CLIA LDT, Medical Device, IVD, Pharmaceutical, or Biotech firm
Responsibilities
  • Lead Quality team to support Quality System processes
  • Develop, manage, maintain, and improve quality metrics
  • Assess and build organizational capability for Quality
  • Drive a culture of compliance within the team
  • Manage Supplier Quality activities
  • Act as Subject Matter Expert in quality processes
  • Mentor and develop personnel
  • Assist in identifying root cause of quality problems
  • Oversee product release to ensure safety and effectiveness
  • Document, review, and approve quality system documentations

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care through accurate genetic insights and early detection of health issues.

Company Stage

IPO

Total Funding

$1.2B

Headquarters

Austin, Texas

Founded

2004

Growth & Insights
Headcount

6 month growth

9%

1 year growth

19%

2 year growth

58%
Simplify Jobs

Simplify's Take

What believers are saying

  • Natera's continuous innovation, such as the launch of the Prospera Heart test with DQS, demonstrates its commitment to improving patient outcomes and maintaining market leadership.
  • The company's diverse product offerings across oncology, transplant health, and women's health provide multiple revenue streams and reduce dependency on a single market.
  • Significant investments from entities like Massachusetts Financial Services Co. MA indicate strong financial backing and confidence in Natera's growth potential.

What critics are saying

  • Allegations of deceptive sales and billing practices could damage Natera's reputation and lead to legal and financial repercussions.
  • The highly competitive nature of the genetic testing market requires constant innovation and differentiation to maintain market share.

What makes Natera unique

  • Natera's focus on cell-free DNA (cfDNA) technology for a wide range of applications, from oncology to prenatal screening, sets it apart from competitors who may specialize in only one area.
  • The introduction of unique features like the Donor Quantity Score (DQS) for transplant rejection detection enhances the accuracy and reliability of their tests, distinguishing them from other genetic testing companies.
  • Natera's extensive portfolio of over 200 peer-reviewed publications underscores its commitment to scientific validation and credibility, which is a significant competitive advantage.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

INACTIVE